Trials / Unknown
UnknownNCT02770664
Study to Evaluate the Efficacy, Safety and PK of Intravenous Single Injection LC28-0126 Immediately Before PCI in STEMI Patients
- Status
- Unknown
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- LG Life Sciences · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
Evaluate the efficacy, Safety and Pharmacokinetics of Intravenous single injection LC28-0126 immediately before Percutaneous Coronary Intervention (PCI) in Patients with ST-segment Elevation Myocardial Infarction (STEMI).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Placebo | Placebo |
| DRUG | LC28-0126 Dose A | LC28-0126 Dose A |
| DRUG | LC28-0126 Dose B | LC28-0126 Dose B |
| DRUG | LC28-0126 Dose C | LC28-0126 Dose C |
Timeline
- Start date
- 2016-04-01
- Primary completion
- 2018-08-01
- First posted
- 2016-05-12
- Last updated
- 2016-05-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02770664. Inclusion in this directory is not an endorsement.